How did CELZ's revenue and expenses trend in Q4 2024?

Concentra's revenue and expenses in Q4 2024 are not available. However, we can infer trends from related data and market analysis. 1. **Revenue Trend**: Concentra's revenue increased by 5.5% year-over-year, reaching $465.0 million in Q4 2024. This growth reflects the company's successful integration of acquired businesses and expansion into new and existing geographies. 2. **Net Income and Earnings Per Share**: The company reported a net income of $22.8 million and earnings per share of $0.17 in Q4 2024. These figures indicate a strong profitability period despite the competitive occupational health services market. 3. **Adjusted EBITDA**: Concentra's Adjusted EBITDA stood at $77.5 million, marking a 13.6% increase from the previous year's $68.3 million. This suggests a strong operational performance and cash flow generation capacity. 4. **Patient Visits**: Patient visits decreased by 2.1% per day compared to Q4 2023, with a total of 2,994,988 visits. This minor decline may warrant attention from management to understand underlying reasons and address potential challenges. 5. **Financial Position**: Concentra ended the year with a robust cash balance of $183.3 million and a manageable net leverage ratio of 3.46x. This financial stability supports the company's strategic initiatives and future growth plans. In conclusion, Concentra demonstrated robust revenue growth, improved profitability, and strong operational performance in Q4 2024, despite a slight decline in patient visits. The company's strategic expansions and integration efforts are evident in its financial outcomes, positioning it well for continued growth in 2025.